Hideki Tokaibayashi
Direttore/Membro del Consiglio presso TELLA, INC.
Profilo
Hideki Tokaibayashi is currently an Outside Director at tella, Inc. and a Representative Director at GranCharite Co. Ltd.
He was previously an Independent Outside Director at Remixpoint, Inc. from 2020 to 2022.
Posizioni attive di Hideki Tokaibayashi
| Società | Posizione | Inizio |
|---|---|---|
| TELLA, INC. | Direttore/Membro del Consiglio | 01/03/2021 |
| GranCharite Co. Ltd. | Direttore/Membro del Consiglio | 01/11/2017 |
Precedenti posizioni note di Hideki Tokaibayashi
| Società | Posizione | Fine |
|---|---|---|
| REMIXPOINT, INC. | Direttore/Membro del Consiglio | 28/06/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REMIXPOINT, INC. | Technology Services |
| Aziende private | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| GranCharite Co. Ltd. |
- Borsa valori
- Insiders
- Hideki Tokaibayashi
